3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide,
APD 791,
APD791,
TEMANOGREL,
887936-68-7,
APD791,
UNII-F42Z27575A,
CHEMBL1084617,
F42Z27575A,
APD-791,
Benzamide, 3-methoxy-N-[3-(1-methyl-1H-pyrazol-5-yl)-4-[2-(4-morpholinyl)ethoxy]phenyl]-,
Benzamide,3-methoxy-N-[3-(1-methyl-1H-pyrazol-5-yl)-4-[2-(4-morpholinyl)ethoxy]phenyl]-,
3-Methoxy-N-[3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl]-benzamide,
Temanogrel [USAN:INN],
APD 791,
Temanogrel (USAN/INN),
SCHEMBL1166554,
DTXSID70237321,
ZEOQUKRCASTCFR-UHFFFAOYSA-N,
BCP24269,
BDBM50319423,
ZINC35920376,
HY-10560,
CS-0002653,
A17094,
D09976,
3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-(morpholin-4- yl)ethoxy)phenyl)benzamide,
3-Methoxy-N-(3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl)- benzamide,
3-methoxy-N-[3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)phenyl]-benzamide,
Benzamide, 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-(4- morpholinyl)ethoxy)phenyl)-,
Temanogrel [USAN],
D0R9KG,
TEMANOGREL HYDROCHLORIDE,
CID11604525,
5-HT 2a inverse agonist (arterial thrombosis), Arena Pharmaceutical,
3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide,